Scarica l'app Stockscreener
100.64
1.89%
1.87
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MIRM Giù?
Forum
Previsione
Mirum Pharmaceuticals Inc Borsa (MIRM) Ultime notizie
Will Mirum Pharmaceuticals' (MIRM) Widening Net Losses Test Its Growth-Focused Investment Narrative? - simplywall.st
Wall Street Zen Downgrades Mirum Pharmaceuticals (NASDAQ:MIRM) to Sell - MarketBeat
Mirum Pharmaceuticals (MIRM) Q2 2026 Earnings Call Transcript - AOL.com
Why Mirum Pharmaceuticals (MIRM) Is Down 6.4% After Raising 2026 Sales Outlook Amid Wider Losses – And What's Next - Yahoo Finance
Janus Henderson Group (MIRM) reports 5.9M Mirum Pharma shares under management - Stock Titan
MIRM Stock Clocks Best Day In 4.5 Months On Liver Disease Trial Data: Retail Eyes Buyout At A Premium - Stocktwits
Mirum Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference - The National Law Review
Insider Selling: Mirum Pharmaceuticals (NASDAQ:MIRM) CFO Sells 6,001 Shares of Stock - MarketBeat
Mirum Pharmaceuticals (MIRM) CFO sells 6,001 shares in Rule 10b5-1 trade - Stock Titan
Mirum Pharmaceuticals (NASDAQ:MIRM) CEO Christopher Peetz Sells 20,000 Shares of Stock - MarketBeat
Mirum Pharmaceuticals CEO Christopher Peetz sells $1.98 million in shares By Investing.com - Investing.com Nigeria
Mirum Pharmaceuticals CEO Christopher Peetz sells $1.98 million in shares - Investing.com
Mirum Pharmaceuticals (MIRM) CEO trades 20,000 shares after option exercise under 10b5-1 plan - Stock Titan
(MIRM) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
MIRM (MIRM) insider files to sell 6,001 shares after recent stock sales - Stock Titan
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule - TradingView
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
What is HC Wainwright's Forecast for MIRM FY2026 Earnings? - MarketBeat
Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A 40% Potential Upside for Investors in Rare Disease Therapies - DirectorsTalk Interviews
Mirum Pharmaceuticals (MIRM) Short Interest & Short Float | Updated Aug 2026 - MarketBeat
Analysts Offer Insights on Healthcare Companies: Mirum Pharmaceuticals (MIRM) and Encompass Health (EHC) - The Globe and Mail
MIRM (MIRM) insider Christopher Peetz plans 20,000-share sale after option exercise - Stock Titan
Hennion & Walsh Asset Management Inc. Sells 56,100 Shares of Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
TD Cowen Maintains Mirum Pharmaceuticals(MIRM.US) With Buy Rating, Maintains Target Price $140 - Moomoo
Q3 EPS Estimate for Mirum Pharmaceuticals Raised by Analyst - MarketBeat
Wall Street Zen Upgrades Mirum Pharmaceuticals (NASDAQ:MIRM) to "Hold" - MarketBeat
A Quick Look at Today's Ratings for Mirum Pharmaceuticals(MIRM.US), With a Forecast Between $118 to $140 - Moomoo
MIRUM PHARMACEUTICALS, INC. : RAYMOND JAMES RAISES TARGET PRICE TO $183 FROM $165 - webull.com
The Manufacturers Life Insurance Company Grows Stock Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
TD Cowen Cuts Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $140.00 - MarketBeat
Mirum Pharmaceuticals, Inc. Stock 12‑Month Price Target Cut to $138.21, Implies 31% Upside - TradingView
Mirum Pharmaceuticals Slides as FDA Feedback Clouds Volixibat Timeline - Quiver Quantitative
Mirum's Q2 Earnings Lag Estimates, Revenues Beat, 2026 View Raised - Yahoo Finance
Mirum Pharmaceuticals (NASDAQ:MIRM) Shares Gap Down Following Weak Earnings - MarketBeat
FMR LLC reveals 6.2% Mirum Pharmaceuticals (MIRM) ownership in Schedule 13G - Stock Titan
RBC Capital Adjusts Mirum Pharmaceuticals PT to $135 From $148, Maintains Outperform Rating - marketscreener.com
HC Wainwright Cuts Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $140.00 - MarketBeat
Citizens Jmp Cuts Mirum Pharmaceuticals (NASDAQ:MIRM) Price Target to $137.00 - MarketBeat
A Quick Look at Today's Ratings for Mirum Pharmaceuticals(MIRM.US), With a Forecast Between $135 to $140 - Moomoo
MIRM SWOT Analysis: Financial Challenges and Growth Potential Re - GuruFocus
Mirum Pharmaceuticals Q2 Earnings Call Highlights - marketbeat.com
MIRUM PHARMACEUTICALS, INC. : H.C. WAINWRIGHT CUTS TARGET PRICE TO $140 FROM $185 - Bitget
Mirum Pharmaceuticals, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Earnings call transcript: Mirum shares sink after Q2 2026 sales beat - Investing.com
Mirum Pharmaceuticals (NASDAQ:MIRM) Announces Earnings Results, Misses Estimates By $0.32 EPS - MarketBeat
MIRM: Q2 sales surged to $176M, guidance raised, and pipeline advances amid regulatory delays - TradingView
Compared to Estimates, Mirum Pharmaceuticals (MIRM) Q2 Earnings: A Look at Key Metrics - Yahoo Finance
Mirum Pharmaceuticals Q2 Loss Widens, Revenue Rises; Shares Fall - Moomoo
Mirum Pharmaceuticals (NASDAQ:MIRM) SVP Jolanda Howe Sells 1,840 Shares of Stock - MarketBeat
Earnings Flash (MIRM) Mirum Pharmaceuticals Posts Q2 Loss -$1.06 per Share - marketscreener.com
Mirum Pharmaceuticals, Inc. (MIRM) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Mirum Pharmaceuticals, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
MIRUM PHARMACEUTICALS ($MIRM) Releases Q2 2026 Earnings - Quiver Quantitative
Mirum Pharmaceuticals, Inc. (MIRM) Q2 FY2026 earnings call transcript - Yahoo Finance
Mirum Pharmaceuticals (MIRM) SVP sells 1,840 shares under 10b5-1 plan - Stock Titan
Mirum Pharmaceuticals Q2 sales rise, lifts outlook - TradingView
Mirum Pharmaceuticals (Nasdaq: MIRM) takes $857M H1 2026 net loss - Stock Titan
Mirum Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update - Yahoo Finance
Mirum Pharmaceuticals (MIRM) Stock Analysis: Unpacking A 40% Upside Potential - directorstalkinterviews.com
Mirum Pharmaceuticals Inc expected to post a loss of 68 cents a shareEarnings Preview - TradingView
MIRM (NASDAQ: MIRM) holder files notice to sell common shares - stocktitan.net
Mirum Pharmaceuticals, Inc. Revenue Breakdown – NASDAQ:MIRM - TradingView
Mirum Pharmaceuticals, Inc. $MIRM Shares Bought by First Trust Advisors LP - MarketBeat
Janus Henderson Group PLC Has $641.76 Million Holdings in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
Mirum Pharmaceuticals, Inc. $MIRM Stake Boosted by Principal Financial Group Inc. - MarketBeat
Mirum Pharmaceuticals Inc (MIRM) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Mirum Pharmaceuticals Inc (MIRM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Mirum Pharmaceuticals Inc (MIRM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Octagon Capital Advisors LP Invests $31.31 Million in Mirum Pharmaceuticals, Inc. $MIRM - MarketBeat
0.52%
0.07%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):